Takeda Weaves Worldwide Web Of Partnerships In Quest For Innovative Drugs, CEO Says
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Facing the imminent expiration of American patents on some of its leading drugs, Takeda is building a matrix of partnerships and licensing arrangements in the quest to strengthen its sales of innovative products, according to CEO Yasuchika Hasegawa